Literature DB >> 12165505

The poststimulation program of CD4 versus CD8 T cells (death versus activation-induced nonresponsiveness).

Ee Loon Tham1, Matthew F Mescher.   

Abstract

Both CD8 and CD4 T cells undergo autocrine IL-2-induced proliferation and clonal expansion following stimulation with Ag and costimulation. The CD8 T cell response is transient because the cells rapidly become activation-induced nonresponsive (AINR) and exhibit split anergy. In these cells, the capacity for IL-2 production is lost, but TCR-mediated IFN-gamma production and cytotoxicity are maintained. At this point, the CTL become dependent on IL-2 provided by CD4 Th cells for continued expansion. If IL-2 is available to support expansion for a brief period, AINR is reversed and the cells regain the ability to produce IL-2. In this study, we show that CD4 T cells do not become AINR, but instead are rendered susceptible to Fas-mediated activation-induced cell death following stimulation through TCR and CD28. Using z-VAD-fmk or anti-Fas ligand mAb to inhibit cell death, we demonstrate that previously activated CD4 T cells retain the ability to up-regulate c-Jun N-terminal kinase activity and IL-2 mRNA levels upon TCR engagement and no longer require costimulation. This rewiring of signaling pathways is similar to that seen following reversal of AINR in CD8 T cells. Thus, CD8 and CD4 T cells appear to use distinct mechanisms, AINR and activation-induced cell death, respectively, to limit excessive clonal expansion following a productive response, while permitting important effector functions to be expressed.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12165505     DOI: 10.4049/jimmunol.169.4.1822

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  10 in total

1.  Regulation of lck degradation and refractory state in CD8+ cytotoxic T lymphocytes.

Authors:  Michael Uhlin; Maria G Masucci; Victor Levitsky
Journal:  Proc Natl Acad Sci U S A       Date:  2005-06-15       Impact factor: 11.205

2.  T helper lymphocytes rescue CTL from activation-induced cell death.

Authors:  Richard Kennedy; Esteban Celis
Journal:  J Immunol       Date:  2006-09-01       Impact factor: 5.422

3.  Evidence of premature immune aging in patients thymectomized during early childhood.

Authors:  Delphine Sauce; Martin Larsen; Solène Fastenackels; Anne Duperrier; Michael Keller; Beatrix Grubeck-Loebenstein; Christophe Ferrand; Patrice Debré; Daniel Sidi; Victor Appay
Journal:  J Clin Invest       Date:  2009-09-21       Impact factor: 14.808

Review 4.  Rethinking peripheral T cell tolerance: checkpoints across a T cell's journey.

Authors:  Mohamed A ElTanbouly; Randolph J Noelle
Journal:  Nat Rev Immunol       Date:  2020-10-19       Impact factor: 53.106

5.  Impaired humoral immunity is associated with prolonged COVID-19 despite robust CD8 T cell responses.

Authors:  Olga Lyudovyk; Justin Y Kim; David Qualls; Madeline A Hwee; Ya-Hui Lin; Sawsan R Boutemine; Yuval Elhanati; Alexander Solovyov; Melanie Douglas; Eunise Chen; N Esther Babady; Lakshmi Ramanathan; Pallavi Vedantam; Chaitanya Bandlamudi; Sigrid Gouma; Philip Wong; Scott E Hensley; Benjamin Greenbaum; Alexander C Huang; Santosha A Vardhana
Journal:  Cancer Cell       Date:  2022-05-30       Impact factor: 38.585

Review 6.  Shaping successful and unsuccessful CD8 T cell responses following infection.

Authors:  Maureen A Cox; Allan J Zajac
Journal:  J Biomed Biotechnol       Date:  2010-03-31

Review 7.  Anti-viral CD8 T cells and the cytokines that they love.

Authors:  Maureen A Cox; Shannon M Kahan; Allan J Zajac
Journal:  Virology       Date:  2013-01-05       Impact factor: 3.616

8.  Rapid identification of MHC class I-restricted antigens relevant to autoimmune diabetes using retrogenic T cells.

Authors:  Rodolfo José Chaparro; Amanda R Burton; David V Serreze; Dario A A Vignali; Teresa P DiLorenzo
Journal:  J Immunol Methods       Date:  2008-04-08       Impact factor: 2.303

Review 9.  Activation-induced non-responsiveness (anergy) limits CD8 T cell responses to tumors.

Authors:  Matthew F Mescher; Flavia E Popescu; Michael Gerner; Chris D Hammerbeck; Julie M Curtsinger
Journal:  Semin Cancer Biol       Date:  2007-06-23       Impact factor: 15.707

10.  Osteoclast-expanded super-charged NK-cells preferentially select and expand CD8+ T cells.

Authors:  Kawaljit Kaur; Meng-Wei Ko; Nick Ohanian; Jessica Cook; Anahid Jewett
Journal:  Sci Rep       Date:  2020-11-23       Impact factor: 4.379

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.